Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Principais autores: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Oxford University Press
2018
|
Registros relacionados
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
por: Wattanakul, T, et al.
Publicado em: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
por: Thanaporn Wattanakul, et al.
Publicado em: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
por: Chotsiri, P, et al.
Publicado em: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
por: Pukrittayakamee, S, et al.
Publicado em: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
por: Saito, M, et al.
Publicado em: (2018)